New Delhi: The recent Goods and Services Tax (GST) reforms are poised to reshape India’s healthcare and pharmaceutical sectors by lowering costs, improving affordability, enhancing efficiency across the value chain while strengthening India’s position as the Pharmacy of the World.

The government’s move to rationalize tax slabs has brought most medicines under a reduced 5 percent GST tax slab rate. Additionally, 36 essential life saving drugs have been completely exempted from GST thereby providing much-needed relief to patients in particular and the healthcare ecosystem in general.

Cancer drugs prices reduced

Over the past year, the prices of major cancer medicines have declined notably, following a series of government-led tax reforms In the Union Budget 2025, the Ministry of Finance

See Full Page